Patient-Reported Outcomes in Adults With Focal-Onset Seizures Who Completed 12 Months of Adjunctive Brivaracetam in Earlier Treatment Lines: Post Hoc Analysis of Interim Real-World Data From BRITOBA
Patient-Reported Outcomes in Adults With Focal-Onset Seizures Who Completed 12 Months of Adjunctive Brivaracetam in Earlier Treatment Lines: Post Hoc Analysis of Interim Real-World Data From BRITOBA
Important Information Related to Your Request:
The material below is provided in response to your specific search
for information on UCBCOMPASS® and may
contain information that is not part of the FDA-approved Prescribing
Information. UCB, Inc. does not recommend or endorse the use of its
products in a manner not consistent with the approved Prescribing
Information. Please review the Full Prescribing
Information.